Hai Hua Bu
Directeur Général chez Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Profil
Hai Hua Bu is currently serving as a Director at Chengdu Hepatunn Pharmaceutical Co. Ltd., an Executive Director at Hepalink (Hong Kong) Co., Ltd., and as a General Manager & Director at Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Prior to his current roles, he served as a Non-Executive Director at Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
from 2006 to 2021.
Mr. Bu holds an MBA from Shanghai Jiao Tong University and an undergraduate degree from Shanghai University of Finance & Economics.
Postes actifs de Hai Hua Bu
Sociétés | Poste | Début |
---|---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Directeur/Membre du Conseil | - |
Hepalink (Hong Kong) Co., Ltd. | Directeur/Membre du Conseil | - |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Directeur Général | - |
Anciens postes connus de Hai Hua Bu
Sociétés | Poste | Fin |
---|---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Directeur/Membre du Conseil | 17/04/2021 |
Formation de Hai Hua Bu
Shanghai Jiao Tong University | Masters Business Admin |
Shanghai University of Finance & Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |
Hepalink (Hong Kong) Co., Ltd. | |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. |